Voltage-gated potassium channel KCNC2

BE0004724ProteinHumansKCNC2

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. It is acted on by 2 drugs in DrugBank.

Gene name
KCNC2
UniProtKB entry
Q96PR1Swiss-Prot
Cellular location
Cell membrane
Residues / weight
638 residues · 70,225 Da
Also known as
Potassium voltage-gated channel subfamily C member 2 · Shaw-like potassium channel · Voltage-gated potassium channel Kv3.2

Resolves to

Protein
UniProtQ96PR1UniProt nameKCNC2_HUMAN
Gene
HGNCHGNC:6234NCBI Gene3747GeneCardsKCNC2
Pharmacology
IUPHAR/GtoPdb549KEGGhsa:3747
Drugs

What you can answer from here — as of September 03, 2024

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
31GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Voltage-gated potassium channel KCNC2, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In